Evidence map›Paper›PMID 25445917›Full record

ReviewThe Journal of steroid biochemistry and molecular biology2015

Novel mechanisms for the vitamin D receptor (VDR) in the skin and in skin cancer.

Daniel D Bikle, Yuko Oda, Chia-Ling Tu, Yan Jiang

Open access · greenAbstract readReview
In one paragraph

Review in The Journal of steroid biochemistry and molecular biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 1 synthesis or guideline pooled it, 73 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Potential Value of a Combination ofPharmaceuticals (Basel, Switzerland) · 2026
    Article
  4. Review
  5. Review
  6. Article
  7. Vitamin D Receptor Regulates the Expression of the Grainyhead-Like 1 Gene.International journal of molecular sciences · 2024
    Article
  8. Structure and the Anticancer Activity of Vitamin D Receptor Agonists.International journal of molecular sciences · 2024
    Review
  9. Article
  10. Review
  11. Article
  12. Inflammaging and Immunosenescence as Part of Skin Aging-A Narrative Review.International journal of molecular sciences · 2023
    Review
  13. Article
  14. Article
  15. Review
  16. The Impact of Vitamin D on Skin Aging.International journal of molecular sciences · 2021
    Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Daniel D BikleDepartment of Medicine and Dermatology, 1700 Owens Street, VA Medical Center and University of California, San Francisco, CA 94158, USA. Electronic address: Daniel.bikle@ucsf.edu.
Yuko OdaDepartment of Medicine and Dermatology, 1700 Owens Street, VA Medical Center and University of California, San Francisco, CA 94158, USA.
Chia-Ling TuDepartment of Medicine and Dermatology, 1700 Owens Street, VA Medical Center and University of California, San Francisco, CA 94158, USA.
Yan JiangDepartment of Medicine and Dermatology, 1700 Owens Street, VA Medical Center and University of California, San Francisco, CA 94158, USA.
University of California, San Francisco · US

Funding

RELATIONSHIP OF PERMEABILITY BARRIER FUNCTION AND EPIDERMAL CYTOKINE PRODUCTIONP01AR039448 · NIAMS · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI ELIAS, PETER M · 1988 to 2007
$11.8M
Vitamin D Receptor Coactivators in KeratinocytesR01AR050023 · NIAMS · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI BIKLE, DANIEL DAVID · 2004 to 2014
$3.4M
NIAMS NIH HHS P01 AR039448NIAMS NIH HHS P01 AR39448NIAMS NIH HHS R01 AR050023
6 · The paper itself

Abstract

The VDR acting with or without its principal ligand 1,25(OH)2D regulates two central processes in the skin, interfollicular epidermal (IFE) differentiation and hair follicle cycling (HFC). Calcium is an important co-regulator with 1,25(OH)2D at least of epidermal differentiation. Knockout of the calcium sensing receptor (CaSR) in addition to VDR accelerates the development of skin cancer in mice on a low calcium diet. Coactivators such as mediator 1 (aka DRIP205) and steroid receptor coactivator 3 (SRC3) regulate VDR function at different stages of the differentiation process, with Med 1 essential for hair follicle differentiation and early stages of epidermal differentiation and proliferation and SRC3 essential for the latter stages of differentiation including formation of the permeability barrier and innate immunity. The corepressor of VDR, hairless (HR), is essential for hair follicle cycling, although its effect on epidermal differentiation in vivo is minimal. In its regulation of HFC and IFE VDR controls two pathways-wnt/β-catenin and sonic hedgehog (SHH). In the absence of VDR these pathways are overexpressed leading to tumor formation. Whereas, VDR binding to β-catenin may block its activation of TCF/LEF1 sites, β-catenin binding to VDR may enhance its activation of VDREs. 1,25(OH)2D promotes but may not be required for these interactions. Suppression of SHH expression by VDR, on the other hand, requires 1,25(OH)2D. The major point of emphasis is that the role of VDR in the skin involves a number of novel mechanisms, both 1,25(OH)2D dependent and independent, that when disrupted interfere with IFE differentiation and HFC, predisposing to cancer formation. This article is part of a Special Issue entitled '17th Vitamin D Workshop'.

Indexed as

AnimalsHumansMiceReceptors, CalcitriolSignal TransductionSkinSkin NeoplasmsVitaminsReceptors, CalcitriolVitaminsCalcium sensing receptorCancerCoregulatorsEpidermal differentiationHair follicle cyclingVitamin D receptor

Identifiers

PMID25445917
PMCPMC4361259
OpenAlexW1998176709

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.